All Practice Exams

100+ Free BCPMP Practice Questions

Pass your Board Certified Pain Management Pharmacist exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
100+ Questions
100% Free
1 / 100
Question 1
Score: 0/0

When advocating for a patient with chronic pain who is denied access to a guideline-recommended therapy due to insurance criteria, the pharmacist should FIRST:

A
B
C
D
to track
2026 Statistics

Key Facts: BCPMP Exam

150

Total Items

125 scored + 25 unscored

3h 45m

Exam Time

BPS

59%

Largest Domain Weight

Therapeutics & Patient Management

Oct 2025

First Administered

BPS

$600

Initial Exam Fee

BPS

500

Passing Scaled Score

Range 200-800

The BCPMP (Board Certified Pain Management Pharmacist) exam is administered by BPS — a newer specialty first administered October 2025. The exam consists of 150 items (125 scored + 25 unscored) over 3 hours 45 minutes, with a passing scaled score of 500. Therapeutics and Patient Management is the largest domain at 59%. The fee is $600 initial / $300 retake. Eligibility requires an active pharmacist license plus qualifying pain management experience or a PGY-2 pain management residency.

Sample BCPMP Practice Questions

Try these sample questions to test your BCPMP exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 58-year-old man develops sharp, shooting, burning pain in a stocking-glove distribution after chemotherapy. Which pain classification BEST describes this presentation?
A.Nociceptive somatic pain
B.Nociceptive visceral pain
C.Neuropathic pain
D.Nociplastic pain
Explanation: Chemotherapy-induced peripheral neuropathy is a classic neuropathic pain syndrome caused by lesion or disease of the somatosensory nervous system. Hallmark descriptors are burning, shooting, electric, tingling, or numb sensations, often in a stocking-glove distribution.
2Which pain assessment tool is BEST suited for nonverbal patients with advanced dementia?
A.Numeric Rating Scale (NRS)
B.Visual Analog Scale (VAS)
C.PAINAD scale
D.McGill Pain Questionnaire
Explanation: The Pain Assessment in Advanced Dementia (PAINAD) scale uses observed behaviors (breathing, vocalization, facial expression, body language, consolability) to score pain 0-10 in patients who cannot self-report.
3A 4-month-old infant is recovering from cardiac surgery. Which validated assessment tool should the team use to quantify postoperative pain?
A.FACES
B.FLACC
C.CRIES
D.PEG-3
Explanation: CRIES (Crying, Requires O2, Increased vital signs, Expression, Sleeplessness) is validated for neonates and infants up to about 6 months following surgery.
4A patient with fibromyalgia describes widespread pain with allodynia and hyperalgesia despite no detectable nerve lesion or active tissue damage. The IASP term that BEST classifies this pain mechanism is:
A.Nociceptive
B.Neuropathic
C.Nociplastic
D.Idiopathic
Explanation: IASP introduced 'nociplastic pain' to describe pain arising from altered nociception (central sensitization) without evidence of actual or threatened tissue damage and without a definable somatosensory lesion. Fibromyalgia is the prototypical nociplastic condition.
5Which statement BEST reflects the biopsychosocial model of pain?
A.Pain is solely a sensory response proportional to tissue damage
B.Pain emerges from interactions of biological, psychological, and social factors
C.Chronic pain is best treated by escalating opioid doses
D.Psychological factors only matter when no physical cause can be identified
Explanation: The biopsychosocial model recognizes that nociception interacts with cognition, emotion, behavior, culture, and environment to produce the pain experience. It guides interdisciplinary care.
6A 6-year-old with sickle cell disease in vaso-occlusive crisis cannot describe pain numerically. Which tool is MOST appropriate?
A.Wong-Baker FACES
B.PAINAD
C.Brief Pain Inventory
D.PEG-3
Explanation: The Wong-Baker FACES Pain Rating Scale is validated for children aged 3 years and older who can match a face to their pain intensity but cannot reliably use a numeric scale.
7A clinic uses the PEG-3 scale at every chronic pain visit. Which three domains does it assess?
A.Pain intensity, enjoyment of life, general activity
B.Pain location, frequency, duration
C.Pain quality, radiation, aggravating factors
D.Pain catastrophizing, depression, sleep
Explanation: PEG-3 captures average Pain intensity (P), interference with Enjoyment of life (E), and interference with General activity (G) on 0-10 scales; the total/3 yields a brief functional measure.
8A new patient with chronic low back pain reports that her previous prescriber 'didn't take my pain seriously because I'm overweight.' Which concept does this BEST illustrate?
A.Nocebo effect
B.Implicit bias and stigma in pain care
C.Catastrophizing
D.Secondary gain
Explanation: Implicit bias and stigma based on weight, race, gender, or substance-use history are well documented contributors to under-assessment and under-treatment of pain. Recognizing and mitigating these biases is part of equitable pain care.
9Visceral nociceptive pain typically presents as:
A.Sharp, well-localized pain at the injured site
B.Burning, electric, shooting pain in a dermatomal pattern
C.Deep, cramping, poorly localized pain that may refer to distant somatic sites
D.Widespread pain with allodynia and central sensitization
Explanation: Visceral pain is mediated by C-fibers from organ capsules and is characteristically dull, cramping, pressure-like, and poorly localized; it commonly refers to somatic sites (e.g., gallbladder pain to the right shoulder).
10Which condition is MOST classically associated with central sensitization as the dominant pain mechanism?
A.Acute appendicitis
B.Diabetic peripheral neuropathy
C.Fibromyalgia
D.Vertebral compression fracture
Explanation: Fibromyalgia is the prototypical central sensitization syndrome, with amplified pain processing, widespread tenderness, fatigue, and disordered sleep, and is therefore classified as nociplastic pain.

About the BCPMP Exam

BPS specialty certification for pharmacists practicing in pain management. The BCPMP validates expertise across pain neurobiology and types, patient assessment (including validated pain tools, opioid risk assessment, and urine drug testing interpretation), evidence-based pharmacologic therapy (opioid, non-opioid, adjuvant, and interventional), opioid stewardship per CDC 2022 guidance, REMS and PDMP requirements, MAT for OUD-pain crossover, and the broader professional and ethical context of pain care. First administered October 2025.

Questions

150 scored questions

Time Limit

3 hours 45 minutes

Passing Score

Scaled 500 (200-800)

Exam Fee

$600 initial / $300 retake (BPS)

BCPMP Exam Content Outline

18%

Pain Management (Principles + Pain Experience)

Pain neurobiology, pathways, types, biopsychosocial model

59%

Therapeutics and Patient Management

Assessment, opioid + non-opioid therapy, equianalgesic conversion, monitoring

23%

Professional Practice

CDC 2022, REMS, PDMP, MAT, naloxone access, ethics, billing

How to Pass the BCPMP Exam

What You Need to Know

  • Passing score: Scaled 500 (200-800)
  • Exam length: 150 questions
  • Time limit: 3 hours 45 minutes
  • Exam fee: $600 initial / $300 retake

Keys to Passing

  • Complete 500+ practice questions
  • Score 80%+ consistently before scheduling
  • Focus on highest-weighted sections
  • Use our AI tutor for tough concepts

BCPMP Study Tips from Top Performers

1Master equianalgesic conversion: morphine 30 mg PO = 10 mg IV = oxycodone 20 mg PO = hydromorphone 7.5 mg PO = 1.5 mg IV. Methadone is non-linear — use methadone-specific tables, NOT linear conversion
2Know the CDC 2022 Opioid Prescribing Guideline updates: removed specific MME thresholds in favor of individualized risk-benefit, but still cautious >50 MME/day and high-risk >90 MME/day
3Memorize FDA REMS programs: ER/LA Opioid Analgesic REMS (educational), iPLEDGE (isotretinoin, not opioid but tested), buprenorphine TIRF REMS, transmucosal immediate-release fentanyl (TIRF) REMS
4Understand opioid risk assessment tools: ORT (5 items, score 0-7+ predicts misuse risk), SOAPP-R (24 items, predicts at-risk patients), COMM (17 items, monitors current chronic pain patients on opioids)
5Complete at least 100 practice questions before scheduling your exam

Frequently Asked Questions

When was the BCPMP exam first administered?

BPS first administered the BCPMP exam in October 2025, making it one of the newer BPS specialty certifications. The 2026 exam window is September 1-21, 2026. As a newer credential there is limited published pass-rate data.

What are the BCPMP eligibility requirements?

You need an active pharmacist license in good standing plus either documented practice experience in pain management OR completion of an ASHP-accredited PGY-2 pain management residency. Specific hours requirements are detailed in the BPS application.

What dominates the BCPMP exam content?

Therapeutics and Patient Management is by far the largest domain at 59% of the exam. This includes patient assessment (validated pain tools, opioid risk assessment with ORT/SOAPP-R, urine drug testing interpretation), therapeutic implementation across opioid/non-opioid/adjuvant/interventional options, equianalgesic conversion (especially the complexity of methadone), and monitoring for adverse effects and outcomes.

What guidelines should I know for the BCPMP exam?

Master the CDC 2022 Opioid Prescribing Guideline (the major update from the 2016 version), ASCO and NCCN cancer pain guidelines, ASRA-Pain Medicine perioperative guidance for buprenorphine continuation, ASH 2020 sickle cell pain, and ACP 2017 low back pain. Know FDA Opioid Analgesic REMS, naloxone standing-order laws, MAT/MATE Acts, and the SUPPORT Act partial-fill provisions.

How should I study for the BCPMP exam?

Plan 80-120 hours over 12-16 weeks. Focus 60-70% of your time on Therapeutics and Patient Management (59%). Master equianalgesic conversion (especially methadone with QTc and complex pharmacokinetics), opioid rotation principles (25-50% reduction for incomplete cross-tolerance), and the CDC 2022 guideline. Use the BPS BCPMP examination specifications PDF as your blueprint.